Intellia Therapeutics, Inc. (NASDAQ:NTLA)

CAPS Rating: 5 out of 5


How do you think NTLA will perform against the market?

Add Stock to CAPS Watchlist

All Players

24 Outperform
0 Underperform

All-Star Players

12 Outperform
0 Underperform

Wall Street

0 Outperform
0 Underperform

Top NTLA Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

OceanJackson (< 20)
Submitted May 10, 2016

While the CRISPR patent dispute is happening, the hype will drive this one higher within the next couple months.

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!


NTLA Summary

Fools bullish on NTLA are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about NTLA.


Member Avatar CMFMLove (37.97) Submitted: 6/12/2017 4:29:42 PM : Outperform Start Price: $12.67 NTLA Score: +85.61

Genomic studies and therapeutic technologies are being revolutionized by the genome editing technology known as CRISPR/Cas9. That technology allows the modification of genes within organisms by ‘editing Clustered regularly interspaced short palindromic repeats (CRISPR), which are segments of prokaryotic DNA made up of short and repetitive base sequences.

There are three principal companies that seek to commercialized CRISPR/CAS9 technologies: Editas Medicine (EDIT), Crispr Therapeutics (CRISPR) and Intellia Therapeutics (NTLA). Each of these companies have plunged over 14 percent each since the publication of a deeply flawed study showing ‘collateral damage’ from gene splicing. Further uncertainly surrounds the field because of disputes between the University of California and the Broad Institute. I think now is a great time to invest in the technology and the companies seeking to commercialized it.

CRISPR/CAS9 techologies will eventually result in significant therapeutic applications, but it is unclear which company will be the big winner. I’m taking a shopping basket approach and picking each company. One of them may go bankrupt, but another one or two will likely be a multi-bagger.


Find the members with the highest scoring picks in NTLA.

Score Leader


CMFMLove (37.97) Score: +85.61

The Score Leader is the player with the highest score across all their picks in NTLA.

Member Name Member
Call Time
Score Commentary
CMFMLove 37.97 6/13/2017 Outperform 5Y $12.67 +97.55% +11.94% +85.61 1 Comment
stereotyp72 70.51 1/24/2017 Outperform 5Y $12.48 +100.56% +20.63% +79.93 0 Comment
prankjt17530 35.08 2/13/2017 Outperform 5Y $13.02 +92.24% +17.68% +74.56 0 Comment
Irishbetter 97.62 3/3/2017 Outperform 5Y $14.40 +73.82% +14.67% +59.15 0 Comment
Playa14 < 20 8/23/2017 Outperform 5Y $17.18 +45.69% +11.78% +33.91 0 Comment
forcel0 94.76 11/23/2016 Outperform 5Y $16.49 +51.79% +24.12% +27.67 0 Comment
clangmead 61.59 12/28/2017 Outperform 5Y $19.40 +29.02% +1.95% +27.07 0 Comment
portefeuille3 98.35 12/27/2017 Outperform 5Y $19.63 +27.51% +2.11% +25.39 0 Comment
mistermiranga 99.57 10/4/2016 Outperform 5Y $16.51 +51.61% +27.39% +24.21 0 Comment
TMFFishBiz 53.28 11/13/2017 Outperform 5Y $20.05 +24.84% +5.74% +19.10 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for NTLA.

Featured Broker Partners